Purchases and Sales Made in Q3 2023 in Milestone Pharmaceuticals Inc. (MIST)
This table provides information about the institutional ownership of Milestone Pharmaceuticals Inc. (MIST) during Q3 2023. The information is specifically focused on institutions that hold shares of Milestone Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
1.21M+ 89.11% |
$3.23M - $4.45M
|
2.56M
$4.76M
|
|
|
Nov 13, 2023
Q3 2023
|
Alta Fundamental Advisers LLC
New York, NY |
BUY
|
- |
278K+ 30.98% |
$746K - $1.03M
|
1.18M
$2.19M
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
130K+ 4.89% |
$347K - $478K
|
2.78M
$5.17M
|
|
|
Nov 14, 2023
Q3 2023
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
35K+ 11.66% |
$93.8K - $129K
|
335K
$623K
|
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
6.18K+ 55.61% |
$16.6K - $22.8K
|
17.3K
$32.2K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
3.44K+ 0.13% |
$9.21K - $12.7K
|
2.56M
$4.76M
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
2.41K+ 0.52% |
$6.46K - $8.9K
|
463K
$861K
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
2.41K+ 9.58% |
$6.46K - $8.9K
|
27.6K
$51.3K
|
|
|
Oct 19, 2023
Q3 2023
|
Valeo Financial Advisors, LLC
|
BUY
|
- |
2K+ 1.68% |
$5.36K - $7.38K
|
121K
$225K
|
|
|
Nov 13, 2023
Q3 2023
|
Envestnet Asset Management Inc
|
BUY
|
- |
918+ 5.08% |
$2.46K - $3.39K
|
19K
$35.3K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
194New |
$520 - $716
|
194
$361
|
|
|
Nov 09, 2023
Q3 2023
|
Oliver Lagore Vanvalin Investment Group
Flint, MI |
BUY
|
- |
100New |
$268 - $369
|
100
$186
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 23, 2023
Q3 2023
|
Clear Creek Financial Management, LLC
|
SELL
|
- |
-500- 1.57% |
$1.34K - $1.85K
|
31.4K
$58.5K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-1.64K- 49.27% |
$4.41K - $6.07K
|
1.69K
$3.15K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.81K- 1.14% |
$7.52K - $10.4K
|
244K
$455K
|
|
|
Nov 15, 2023
Q3 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-17.5K- 26.45% |
$47K - $64.7K
|
48.8K
$90.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-53.9K- 32.26% |
$144K - $199K
|
113K
$211K
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-93.1K- 51.75% |
$250K - $344K
|
86.8K
$162K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-104K- 12.97% |
$280K - $385K
|
701K
$1.3M
|
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-155K- 19.39% |
$416K - $573K
|
645K
$1.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-173K- 36.92% |
$465K - $640K
|
296K
$551K
|